Home › Funds › Gildi - lifeyrissjodur › OCS

Gildi - lifeyrissjodur position in OCS

OCULIS HOLDING AG · Health Care

Gildi - lifeyrissjodur reported holding 2,430,401 shares of OCS (OCULIS HOLDING AG) in its Q1 2026 13F filing — a position valued at US$64.3M, representing 32.62% of its reported portfolio and ranking #2 among its reported holdings. Gildi - lifeyrissjodur has disclosed OCS holdings in 2 of the last 2 reported quarters, going back to Q4 2025.

Latest position (Q1 2026)2.43M sh
Reported value held$64.32M
Portfolio Weight32.62%
First reportedQ4 2025
Last changeReduce
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Gildi - lifeyrissjodur's OCS position evolved

Gildi - lifeyrissjodur first disclosed a stake in OCS in Q4 2025 at 2,447,985 shares (US$50.3M). The position peaked in Q1 2026 at 2,430,401 shares, worth US$64.3M. Across 2 filings, Gildi - lifeyrissjodur increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 2,430,401 shares valued at US$64.3M — a reduction of -17,584 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 2.45M $50.25M New
Q1 2026 2.43M $64.32M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OCS and 13F data

OCS (OCULIS HOLDING AG) is a Health Care company. 64 other funds we track also report a position in OCS — the largest reported positions include EQT Fund Management S.a r.l. (US$96.4M), Pivotal bioVenture Partners Investment Advisor LLC (US$20.9M), Saturn V Capital Management LP (US$9.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OCS

All OCS fund holders →

FAQ

How long has Gildi - lifeyrissjodur held OCS?

Gildi - lifeyrissjodur has disclosed OCS holdings in 2 of the last 2 reported quarters, going back to Q4 2025.

What is Gildi - lifeyrissjodur's current position in OCS?

As of Q1 2026, Gildi - lifeyrissjodur holds 2.43M shares of OCS (OCULIS HOLDING AG), valued at $64.32M, representing 32.62% of its reported portfolio and ranking #2.

Has Gildi - lifeyrissjodur been buying or selling OCS?

In the latest 13F filing (Q1 2026), Gildi - lifeyrissjodur reduced its position in OCS. The position peaked in Q1 2026 at 2.43M shares.

Which other funds hold OCS?

Other major institutional holders of OCS include EQT Fund Management S.a r.l., Pivotal bioVenture Partners Investment Advisor LLC, Saturn V Capital Management LP, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.